- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04481893
Interest of the Virtual Reality Headset in the Management of Perioperative Stress in Patients Candidates for Total Thyroidectomy (ThyroVir)
September 15, 2025 updated by: Centre Francois Baclesse
Study the interest of hypnosis techniques by virtual reality based on the use of a virtual reality headset with the AQUA® application on the reduction of pre-operative stress in patients candidates for total thyroidectomy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
82
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Caen, France
- CHU caen
-
Caen, France
- Centre Francois Baclesse
-
Rouen, France
- Clinique Mathilde
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient> 18 years old
- Man or woman
- Patient candidate for a total thyroidectomy, or a thyroid totalization
- Preoperative Euthyroidism
- Can justify outpatient care: score of the American Society of Anesthesiology (ASA) 1, 2 or 3 stable; accompanied for return at home; can be watched by a loved one the night after returning home; reachable by telephone; living within an hour of transportation from a hospital and having a good level of understanding.
- No history of parathyroid or recurrent pathology
- Signature of informed consent before any specific procedure related to the study
- Subject affiliated with a health security system
Exclusion Criteria:
- Patient with a submerged goiter (lower edge of the thyroid not seen on the preoperative cervical ultrasound)
- Patient with uncontrolled infectious pathology
- Pregnant or breastfeeding woman or lack of contraception during genital activity
- Patient with illnesses or conditions that hinder their ability to understand follow and / or comply with study procedures
- Patient with personality disorders and / or psychiatric pathology
- Patient deprived of liberty or placed under the authority of a guardian
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: using a virtual reality headset
|
The intervention will consist of 2 sessions of 30 minutes each, based on the use of a virtual reality headset with the AQUA® application.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Anxiety state (STAI-Y scale)
Time Frame: Before surgery and up to 2 hours after surgery
|
The proportion of patients whose pre-operative anxiety state (STAI-Y scale)is improved or stable between before and after the session with virtual reality headset.
These two measurements will allow us to appreciate the variations in patient anxiety.
|
Before surgery and up to 2 hours after surgery
|
|
Change of Anxiety state(AE scale)
Time Frame: Before surgery and up to 2 hours after surgery
|
The proportion of patients whose preoperative anxiety state (AE) is improved or stable between before and after the session with virtual reality headset.
These two measurements will allow us to appreciate the variations in patient anxiety.
|
Before surgery and up to 2 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety evaluation by Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Time Frame: up to 1 month after surgery
|
Anxiety score [minimum value 0 , up to maximum value (worse) 20] according to the Amsterdam Pre-operative Anxiety and Information Scale (APAIS)
|
up to 1 month after surgery
|
|
Pain evaluation (Visual Analog Pain Scale)
Time Frame: up to 1 month after surgery
|
Score on the VAS pain scale [minimum value 0, up to maximum value (worse) 10]
|
up to 1 month after surgery
|
|
Satisfaction of patients by EVAN-G scale (Evaluation of the General Anesthesia feelings)
Time Frame: Up to 2 hours after surgery
|
score of EVAN-G questionnaire [minimum value 0, up to maximum value (worse) 100]
|
Up to 2 hours after surgery
|
|
Taking of anxiolytics
Time Frame: up to 1 month after surgery
|
variation of amount of anti-anxiety medication
|
up to 1 month after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 18, 2020
Primary Completion (Actual)
June 6, 2025
Study Completion (Actual)
June 6, 2025
Study Registration Dates
First Submitted
July 7, 2020
First Submitted That Met QC Criteria
July 21, 2020
First Posted (Actual)
July 22, 2020
Study Record Updates
Last Update Posted (Estimated)
September 18, 2025
Last Update Submitted That Met QC Criteria
September 15, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-A00182-37
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Cancer
-
National Cancer Institute (NCI)TerminatedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Anaplastic Thyroid Cancer | Stage III Follicular Thyroid Cancer | Stage III Papillary Thyroid CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); GlaxoSmithKline; National Comprehensive Cancer...CompletedRecurrent Thyroid Cancer | Stage IVA Follicular Thyroid Cancer | Stage IVA Papillary Thyroid Cancer | Stage IVB Follicular Thyroid Cancer | Stage IVB Papillary Thyroid Cancer | Stage IVC Follicular Thyroid Cancer | Stage IVC Papillary Thyroid CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Cancer | Stage IVA Follicular Thyroid Cancer | Stage IVA Papillary Thyroid Cancer | Stage IVB Follicular Thyroid Cancer | Stage IVB Papillary Thyroid Cancer | Stage IVC Follicular Thyroid Cancer | Stage IVC Papillary Thyroid CancerUnited States
-
Children's Hospital of PhiladelphiaEli Lilly and Company; United States Department of DefenseRecruitingCancer | Pediatric Cancer | Differentiated Thyroid Cancer | Cancer, ThyroidUnited States
-
National Cancer Institute (NCI)CompletedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid CancerUnited States
-
University of PennsylvaniaCompletedMetastatic Medullary Thyroid Cancer | Metastatic Differentiated Thyroid Cancer | Metastatic Anaplastic Thyroid Cancer | Metastatic Poorly Differentiated Thyroid CancerUnited States
-
Children's Hospital of PhiladelphiaBayerRecruitingCancer | Pediatric Cancer | Differentiated Thyroid Cancer | Cancer, ThyroidUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedThyroid Cancer, Medullary | Thyroid Cancer | Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Poorly Differentiated Thyroid Gland Carcinoma | Follicular Thyroid CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid CancerUnited States
-
Bhavana KondaNational Comprehensive Cancer NetworkCompletedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Papillary Thyroid Cancer | Follicular Thyroid CancerUnited States
Clinical Trials on Use of a virtual reality headset
-
The Leeds Teaching Hospitals NHS TrustCompleted
-
Assistance Publique - Hôpitaux de ParisVR 4 GOODRecruitingPain, Postoperative | Colon Tumor, Malignant | Rectum TumorFrance
-
Royal Cornwall Hospitals TrustCompletedPalliative Care | Hematologic Malignancy | Oncology | End Stage CancerUnited Kingdom
-
University of California, DavisCompleted
-
Dartmouth-Hitchcock Medical CenterNot yet recruiting
-
University Health Network, TorontoMichael Garron Hospital; Centre for Aging and Brain Health InnovationTerminatedDementia | Delirium Superimposed on DementiaCanada
-
Ruhr University of BochumCompletedPain | Anxiety | Cervical DysplasiaGermany
-
Spaulding Rehabilitation HospitalCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Istituto Ortopedico RizzoliRecruitingPreoperative AnxietyItaly